Infliximab Accelerated Induction in Moderate to Severe Pediatric UC

NCT03209232 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
10
Enrollment
OTHER
Sponsor class

Stopped Difficulty to recruit patients and as high dose infliximab for severe UC is now the rule rather than the exception

Conditions

Interventions

Sponsor

Schneider Children's Medical Center, Israel